mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |